Is it safe to administer a single 30‑mg intramuscular dose of ketorolac (Toradol) to an adult patient with an estimated glomerular filtration rate of 57 mL/min/1.73 m²?

Ketorolac 30 mg IM with eGFR 57: Proceed with Caution

A single 30 mg IM dose of ketorolac can be administered to a patient with an eGFR of 57 mL/min/1.73 m², but use the lower dose of 15 mg instead to minimize nephrotoxicity risk, especially if other risk factors for acute kidney injury are present.

Dosing Considerations in Renal Impairment

The available evidence indicates that ketorolac dosing should be adjusted when renal function is compromised, though the threshold varies:

• Standard dosing recommendations suggest lower doses (15-30 mg range) for patients with impaired kidney function 1
• Your patient's eGFR of 57 mL/min/1.73 m² represents mild-to-moderate renal impairment (Stage 2-3a CKD)
• While not meeting the severe impairment threshold (eGFR <30 mL/min/1.73 m²) where ketorolac should be avoided entirely 2, this patient sits in a gray zone requiring caution

Risk Assessment Framework

Key risk factors that increase nephrotoxicity concern:

• Volume depletion or hypoperfusion states - NSAIDs block compensatory prostaglandin-mediated renal vasodilation 3
• Concurrent nephrotoxic medications (ACE inhibitors, ARBs, diuretics, aminoglycosides)
• Advanced age (>65 years)
• Baseline proteinuria or active kidney disease
• Recent major surgery with third-spacing of fluids 3

The literature documents acute renal failure even after single doses of ketorolac 4, particularly in vulnerable patients. One study showed ketorolac was an independent risk factor for long-term renal dysfunction after nephrectomy 5.

Practical Recommendation Algorithm

If you must use ketorolac in this patient:

1. Reduce the dose to 15 mg IM rather than 30 mg - this provides adequate analgesia with lower nephrotoxicity risk 1
2. Ensure adequate hydration status before administration
3. Limit to single dose only - avoid scheduled dosing or multi-day regimens
4. Monitor urine output for 24-48 hours post-administration 3
5. Check serum creatinine at 48-72 hours if clinically indicated

Consider alternative analgesics:

• Acetaminophen (no renal dose adjustment needed)
• Opioids without active metabolites (fentanyl preferred over morphine/codeine in renal impairment) 2
• Regional anesthesia techniques when applicable

Critical Caveats

The nephrotoxicity risk is highest when renal perfusion is already compromised. Even with eGFR 57, if your patient is volume depleted, hypotensive, on multiple nephrotoxic agents, or post-operative with significant fluid shifts, avoid ketorolac entirely 3. The risk-benefit calculation shifts dramatically in these contexts, where case reports demonstrate acute renal failure from single doses 4.

Recent evidence on dual NSAID use showed no increased AKI risk when combining ketorolac with acetaminophen/ibuprofen in renal surgery patients 6, but this doesn't negate the baseline risk in patients with pre-existing renal impairment.

The safest approach: use 15 mg IM as a single dose with close monitoring, or choose a non-NSAID alternative if any additional risk factors are present.